“Nautilus embodies what we call the Alexandria Experience,” said Daniel J. Ryan, Executive Vice President and Regional Market Director at Alexandria. “For Alexandria’s client tenants, we not only provide the ideal real estate solution, we provide a lifestyle. We are focused on helping the brightest scientific minds improve their productivity, their wellness, their recruitment and retention and, most importantly, accelerate the development of novel, breakthrough products that will improve the human condition.”Nautilus is a highly sustainable facility which has been designed to achieve LEED ® Gold Core and Shell certification as recognized by the U.S. Green Building Council (USGBC). Some of the facility’s sustainable features include two buildings projected to perform approximately 15 percent better than the national standard for energy efficiency; high-efficiency glazing and lighting systems, and a “cool roof” to reduce baseline energy consumption; significantly reduced water consumption both inside and outside of the buildings; a drought-tolerant plant palette in combination with a high-efficiency irrigation system that reduces water consumption outside the building by more than 50 percent; and fitness rooms and showering facilities providing client tenants with a place to refresh after walking or biking to work. Founded in 1994, with its first assets located in the Torrey Pines submarket, Alexandria pioneered the Labspace ® niche on the belief that life science entities are most successful when located in the nation’s top life science clusters, like Torrey Pines, adjacent to world-renowned academic and medical institutions, cutting-edge scientific and managerial talent, and sophisticated capital. Alexandria has remained steadfast in its cluster development model, earning a reputation as San Diego’s leading owner, operator, and developer of best-in-class life science facilities in the Torrey Pines, University Town Center (UTC), and Sorrento Valley submarkets. Alexandria currently has a leading collection of high-quality client tenants in San Diego including Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, Illumina, Inc., Novartis AG, and The Scripps Research Institute. About Alexandria Real Estate Equities, Inc. Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed real estate investment trust (REIT), is the largest and leading investment-grade REIT focused principally on owning, operating, and developing high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, U.S. government research agencies, medical device companies, clean technology companies, venture capitalists, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations adjacent to leading academic and medical institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For more information, please visit www.are.com. This press release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.